Results

Total Results: over 10,000 records

Showing results for "reason".

9881. Reducing Hospital Readmission Rates by Implementing an Inpatient Tobacco Cessation Service Driven by Interactive-Voice Recognition (IVR) Technology - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r21hs023863-cartmell-final-report-2018.pdf
      January 01, 2018 - Reducing Hospital Readmission Rates by Implementing an Inpatient Tobacco Cessation Service Driven by Interactive-Voice Recognition (IVR) Technology - Final Report FINAL PROGRESS REPORT 1. TITLE PAGE Title: Reducing Hospital Readmission Rates by Implementing an Inpatient Tobacco Cessation Service Driven by In…

9882. Final Progress Report: Risk-Informed Interventions in Community Pharmacy: Implementation and Evaluation (pdf file)
      www.ahrq.gov/sites/default/files/2024-02/cohen2-report.pdf
      January 01, 2024 - All (100%) were advised to ask their doctor to list the reason for the medication on future prescriptions

9883. Lessons Learned From AHRQ’s State and Regional Demonstrations in Health Information Technology (pdf file)
      digital.ahrq.gov/sites/default/files/docs/page/SRD_LessonsLearned_0.pdf
      October 01, 2010 - For this reason, HIOs should ensure that they have adequate capital to maintain the initiative until

9884. Scaling, Measurement, and Dissemination of CDS Workgroup: Approaches to Measuring Patient-Centered CDS Workflow and Lifeflow Impact (pdf file)
      cdsic.ahrq.gov/sites/default/files/2023-08/SMD%20Workflow%20Measurement%20Approaches%20Report_to%20AHRQ%208.9.23_508.pdf
      January 01, 2023 - the final list of eligible records for data abstraction, and for ineligible records, documented the reason

9885. CEDAR Option Period Outreach Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/ahrq_cedar_outreach_report_final.pdf
      September 01, 2023 - The reason why individuals who were invited to the informal conversations or the formal Pilot focus

9886. Head-Neck-Cancer-Update Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer-update_executive.pdf
      December 01, 2014 - The reason for excluding each article retrieved in full text was recorded in the Distiller database

9887. Colorectal-Cancer-Liver-Metastases-Therapies Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_executive.pdf
      December 01, 2012 - Because the literature was so heterogeneous in terms of the populations (e.g., prior treatments, reason

9888. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
      March 01, 2012 - Accessed January 19, 2012 1 Background Hypertension is the most common reason older adults

9889. INTRODUCTION TO THE HCUP NATIONWIDE INPATIENT SAMPLE (NIS), 2006
      hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2006.jsp
      January 01, 2006 - INTRODUCTION TO THE HCUP NATIONWIDE INPATIENT SAMPLE (NIS), 2006 An official website of the Department of Health & Human Services Search All AHRQ Websites Careers Contact Us Espanol …

9890. ACKNOWLEDGEMENTS (pdf file)
      hcup-us.ahrq.gov/reports/race/NASHPDisparitiesReport.pdf
      January 01, 2020 - For this reason, many featured states that have an action plan for reducing disparities also have a

9891. Person-Centered Preventive Healthcare: Engaging in Challenging Conversations about Screening (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/research/engaging-challenging-full.pdf
      May 01, 2024 - Person-Centered Preventive Healthcare: Engaging in Challenging Conversations about Screening Person-Centered Preventive Healthcare: Engaging in Challenging Conversations about Screening Prepared for Agency for Healthcare Research and Quality Center for Evidence and Practice Improvement Prepared by …

9892. Overview of Patient Safety Learning Laboratory (PSLL) Projects | Agency for Healthcare Research and Quality
      www.ahrq.gov/patient-safety/resources/learning-lab/index.html
      August 01, 2025 - Overview of Patient Safety Learning Laboratory (PSLL) Projects Introduction Patient safety learning laboratories (PSLLs) take a systems engineering approach to allow researchers and healthcare providers to evaluate clinical processes and enhance work and information flow to improve patient safety. The learning …

9893. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
      July 01, 2022 - Key to exclusion codes Exclusion Code Exclusion Reason 2 Ineligible outcome 3 Ineligible intervention

9894. Cesarean Section | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/cesarean-section

9895. Birth Weight | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/birth-weight

9896. Archived: Evidence Summary: Bleeding Risks With Aspirin Use: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
      April 11, 2016 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary: Bleeding Risks With Aspirin Use Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication April 11, 2016 Recomme…

9897. Kidney-Disease-Medicine Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
      January 01, 2012 - 1 Comparative Effectiveness Review Number 37 Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and Treatment Executive Summary Objectives This systematic review evaluates the evidence regarding the potential benefits and harms of: (1) screening adults for early-stage chronic kidney disease (CKD stages…

9898. Medicare-Medication-Use Research (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
      April 01, 2014 - Medication use among Medicare beneficiaries with medical and psychiatric conditions, 2009-2011 Medication Use in Medicare Data Points #19 Within the Medicare population, the major- ity of beneficiaries who have a psychiatric diagnosis also have one or more medical diagnoses. Use of multiple medications is common …

9899. Overview to the HCUP Nationwide Inpatient Sample (NIS), 2001
      hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2001.jsp
      January 01, 2001 - Overview to the HCUP Nationwide Inpatient Sample (NIS), 2001 An official website of the Department of Health & Human Services Search All AHRQ Websites Careers Contact Us Espanol …

9900. Considering the Range of Decision-Relevant Effects (ppt file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-choosing-outcomes.ppt
      June 01, 2012 - Considering the Range of Decision-Relevant Effects Choosing the Important Outcomes for a Systematic Review of a Medical Test Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Medical Test Reviews Methods Guide www.ahrq.gov Choosing the Important Outcomes for a Systematic Revi…